Tsumura

Minato, Japan Founded: 1893 • Age: 133 yrs Listed
Manufacturer and distributor of Kampo herbal medicines

About Tsumura

Tsumura is a publicly listed company based in Minato (Japan) founded in 1893. The company has 4,270 employees. Tsumura has completed 1 acquisition, including Shaanxi Ziguang Chenji Pharmaceutical. Its website tsumura.co.jp draws about 1.2 million monthly visits. Tsumura offers products and services including Kampo Formulations and General-Use Kampo Medicines. Its focus areas include Traditional Pharmaceuticals and Diversified. Its legal entity is TSUMURA & CO.

Company details

Manufacturer and distributor of Kampo herbal medicines. This company develops, produces, and distributes both prescription and over-the-counter Kampo medicines. Their operations encompass the entire value chain, from cultivating raw materials to quality control and distribution. The company also conducts research and development in the field of Kampo medicine, including exploring individualized treatment approaches. They provide educational resources on Kampo medicine for both healthcare professionals and the general public.

  • Headquarters Minato, Japan
  • Employees 4,270
  • Stage Public
  • Sectors
    Healthcare
  • Website category Health
  • Website tsumura.co.jp
  • Social LinkedIn
  • Legal Name Tsumura & Co.
Key Metrics
  • Annual Revenue
    $1.21 B (USD)
    6.36
    as on Mar 31, 2026
  • Net Profit
    $176.3 M (USD)
    -13.29
    as on Mar 31, 2026
  • EBITDA
    $302.7 M (USD)
    -5.88
    as on Mar 31, 2026
  • Employee Count
    4,270
  • Investments & Acquisitions

Products & Services of Tsumura

Tsumura offers a comprehensive portfolio of products and services, including Kampo Formulations and General-Use Kampo Medicines.

Kampo Formulations
Medical Products

Medical Kampo formulations are developed and supplied for therapeutic uses, drawing from traditional herbal medicine practices.

General-Use Kampo Medicines
Wellness Products

General-use Kampo medicines are made available for over-the-counter purchase, supporting everyday health needs through herbal remedies.

People of Tsumura

1 people are tracked at Tsumura (1 in leadership); the tracked headcount is 4,270.

NameRoleGroup
Terukazu Kato
Chief Executive Officer, President, and DirectorLeadership
Premium access

Complete people profiles for Tsumura

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Tsumura

Tsumura is a publicly listed company on the TSE with ticker symbol 4540 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date21 Nov 1980
  • Listed onTSE: 4540
  • Listed entityTsumura & Co.
  • Exchange sectorHealth technology
  • ISINJP3535800001
  • Share price3,795.00 JPY (-0.76% on the day) · 2026-10-14
  • Market capitalisation292,564,941,406.00 JPY
  • Price to earnings9.4
  • EPS (diluted, trailing year)405.52 JPY
  • Dividend yield4.19%
  • Volume (last session)341,400

Financials of Tsumura

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025192.62B JPY28.12B JPY48.28B JPY
2024181.09B JPY32.43B JPY51.30B JPY
2023150.84B JPY16.71B JPY30.77B JPY
2022140.04B JPY16.48B JPY31.53B JPY
2021129.55B JPY18.84B JPY31.57B JPY
Premium access

Detailed financial statements for Tsumura

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Tsumura

Tsumura has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Shaanxi Ziguang Chenji Pharmaceutical.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Diversified pharmaceutical research technologies are provided by the company.
cjyy.com.cnBaoji, China1918Apr 2023$36.53M
Premium access

Complete acquisition details for Tsumura

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Tsumura

3 dated milestones of Tsumura across 130 years, from founding to its latest funding, stage changes and deals.

  1. Founded Tsumura is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Shaanxi Ziguang Chenji Pharmaceutical.

Web traffic of Tsumura

The website of Tsumura (tsumura.co.jp) receives about 1.2M visits a month and ranks #59,123 among all websites worldwide, #1,580 in Health.

  • Monthly visits
    1.2M

    ▲ 9.7% vs previous month

  • Unique visitors
    663.6K

    per month

  • Global rank
    #59,123

    among all websites

  • Category rank
    #1,580

    Health · Health

Similar websites

Websites whose visitors overlap most with Tsumura. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
kracie.co.jp
100%
1.8M#39,659View details
sugamo-sengoku-hifu.jp
74%
#111,759View details
medpeer.jp
medpeer.jp
64%
#21,619–
kobayashi.co.jp
60%
1.9M#32,565View details
medical-tribune.co.jp
57%
473.6K#99,141View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Tsumura

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Tsumura

Premium access

Complete news archive for Tsumura

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tsumura

Tsumura was founded in 1893.

Tsumura is headquartered in Minato, Japan. It is registered at Minato, Tokyo, Japan.

Tsumura has 4,270 employees.

Annual revenue of Tsumura is $1.21B as on Mar 31, 2026.

Manufacturer and distributor of Kampo herbal medicines. This company develops, produces, and distributes both prescription and over-the-counter Kampo medicines. Their operations encompass the entire value chain, from cultivating raw materials to quality control and distribution. The company also conducts research and development in the field of Kampo medicine, including exploring individualized treatment approaches. They provide educational resources on Kampo medicine for both healthcare professionals and the general public.

Tsumura offers Kampo Formulations and General-Use Kampo Medicines.

Yes, Tsumura is publicly traded on TSE under the ticker symbol 4540.

Tsumura has made 1 acquisition, including Shaanxi Ziguang Chenji Pharmaceutical.

Tsumura operates through Tsumura & Co..

The website of Tsumura receives about 1.2 million visits a month and ranks #59,123 among all websites worldwide.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available